ID   MGLVA1
AC   CVCL_RM03
DR   cancercelllines; CVCL_RM03
DR   Wikidata; Q54905483
RX   PubMed=10562577;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg110Cys (c.328C>T); ClinVar=VCV000142206; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RM02 ! MKN45G
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 05-10-23; Version: 9
//
RX   PubMed=10562577; DOI=10.1136/gut.45.6.812;
RA   Watson S.A., Morris T.M., Varro A., Michaeli D., Smith A.M.;
RT   "A comparison of the therapeutic effectiveness of gastrin
RT   neutralisation in two human gastric cancer models: relation to
RT   endocrine and autocrine/paracrine gastrin mediated growth.";
RL   Gut 45:812-817(1999).
//